CareTrust REIT (CTRE) Files for Automatic Mixed Securities Shelf
CareTrust REIT (CTRE) has filed an automatic mixed securities shelf registration to gain flexibility in accessing capital markets, supporting its financial growth and operational initiatives. The company shows strong profitability with high gross and EBITDA margins, despite a recent decline in revenue growth. While its valuation metrics suggest a premium position and analyst sentiment is positive, investors should be mindful of its high dividend payout ratio and current valuation.
CareTrust REIT files for up to $1B at-the-market program
CareTrust REIT has filed an at-the-market offering prospectus to sell up to $1 billion of its common stock. This program allows the company to opportunistically raise capital over time, providing financial flexibility for future operations or investments.
UBS Maintains Buy Rating for CareTrust REIT (CTRE) and Raises Pr
UBS analyst Michael Goldsmith reiterated a Buy rating for CareTrust REIT (CTRE) and increased the price target from $44.00 to $48.00 due to a positive outlook. This update follows a series of recent upward adjustments in price targets from other analysts, collectively signaling a favorable market perception for CTRE. CareTrust REIT specializes in owning, acquiring, and leasing healthcare-related properties, generating revenue primarily from domestic triple-net lease agreements.
On February 17, CareTrust REIT Inc (referred to as CareTrust) and its affiliate CTR Partnership, L.P. jointly announced the completion of a new equity distribution agreement.
CareTrust REIT Inc. and its affiliate CTR Partnership, L.P. announced on February 17 the completion of a new equity distribution agreement. This agreement, detailed in SEC filings, is expected to enhance CareTrust's capital liquidity and provide flexibility for future strategic planning. Market participants are monitoring its potential positive impact on the company's long-term value.
Expert Outlook: CareTrust REIT Through The Eyes Of 7 Analysts
Seven analysts have recently evaluated CareTrust REIT (NYSE: CTRE), with their ratings ranging from bullish to indifferent. The average 12-month price target for CTRE is $42.29, marking a 7.53% increase from the previous average. CareTrust REIT shows strong financial performance with high revenue growth, net margin, ROE, and ROA, alongside a healthy debt-to-equity ratio.
CareTrust REIT (NASDAQ:CTRE) Sets New 1-Year High - Still a Buy?
CareTrust REIT (CTRE) recently reached a new 52-week high of $40.81, with analysts generally rating it a "Moderate Buy" and some raising price targets. The REIT offers a 3.3% dividend yield, though its payout ratio is high at 86.45%. With a market cap of $9.12 billion and a low debt-to-equity ratio, institutional investors hold a significant portion of its shares.
Caretrust Inc stock hits all-time high of 40.75 USD
Caretrust Inc (CTRE) stock reached an all-time high of $40.75 USD, exhibiting a 54.06% increase over the past year and demonstrating strong investor confidence. Despite reporting a mixed Q4 2025 earnings with an EPS miss but a revenue beat, the company maintains a "GREAT" financial health score, driven by strategic expansions and favorable market conditions. Caretrust Inc, a healthcare real estate investment trust, also boasts a 10-year dividend increase streak, currently yielding 3.35%.
Rhumbline Advisers Purchases 60,604 Shares of CareTrust REIT, Inc. $CTRE
Rhumbline Advisers increased its stake in CareTrust REIT (NASDAQ:CTRE) by 10.3% in the third quarter, acquiring 60,604 additional shares to bring its total holdings to 649,675 shares valued at approximately $22.53 million. CareTrust REIT pays a quarterly dividend of $0.335, resulting in an annualized yield of 3.3%. Wall Street analysts have a "Moderate Buy" consensus rating with an average price target of $39.00 for the company.
CareTrust REIT, Sabra Health Care REIT look to 2026 investments
CareTrust REIT and Sabra Health Care REIT are both optimistic about investment opportunities in 2026, building on their strong performance in 2025. CareTrust REIT has a $500 million investment pipeline focusing on US senior housing and UK care homes, while Sabra Health Care REIT's pipeline is robust with $240 million in investments, primarily in senior living. Both REITs anticipate surpassing their 2025 transaction volumes, noting continued strong deal flow across various healthcare sectors.
CareTrust REIT’s Record Investments Test A More Complex Growth Model
CareTrust REIT (NYSE: CTRE) has undergone a significant transformation, reporting record investments of US$1.8 billion in its latest fiscal year, including entry into the UK care home market and its first seniors housing operating (SHOP) deal. This shift moves the company from a simple triple net landlord model to a more complex, multi-platform healthcare REIT, introducing new growth opportunities but also increased operational and financial risks. While earnings and FFO per share are growing, the market is evaluating whether its expanded, more diversified platform can justify current valuation metrics given potential integration, regulatory, and execution challenges.
Public Sector Pension Investment Board Buys 205,757 Shares of CareTrust REIT, Inc. $CTRE
The Public Sector Pension Investment Board increased its stake in CareTrust REIT (CTRE) by 31.5% in the third quarter, acquiring an additional 205,757 shares, bringing its total to 859,256 shares valued at approximately $29.8 million. CareTrust REIT maintains a "Moderate Buy" consensus rating from analysts with an average target price of $39.00, and it offers a quarterly dividend of $0.335, representing an annualized yield of about 3.3%. The company, a healthcare-focused REIT, has a market capitalization of $8.94 billion and a trailing P/E of 50.65.
CareTrust REIT Inc (NYSE:CTRE) Fits the Minervini Growth Model with Strong Trend and Momentum
CareTrust REIT Inc (NYSE:CTRE) aligns with Mark Minervini's growth model, demonstrating a strong technical uptrend and robust fundamental growth. The stock meets Minervini's Trend Template criteria with its price above key moving averages and high relative strength, alongside significant improvements in quarterly and yearly earnings and sales. Although its technical condition is excellent, the current low setup quality rating suggests waiting for a less volatile entry point.
CareTrust REIT Posts Strong Quarter and Upbeat 2026 Outlook
CareTrust REIT (CTRE) reported a strong financial performance for the quarter and full year ending December 31, 2025, with net income nearly doubling year-over-year and significant growth in FFO and FAD per share. The company demonstrated strategic growth through investments and equity raises, maintained its dividend, and provided optimistic 2026 guidance, reinforcing its competitive position in healthcare real estate. An AI analyst from TipRanks classifies CTRE as "Outperform" due to its robust financial health and strategic expansions despite a high P/E ratio.
CareTrust REIT, Inc. (NYSE:CTRE) Q4 2025 Earnings Call Transcript
CareTrust REIT, Inc. (CTRE) held its Q4 2025 earnings call, highlighting 2025 as a transformative year with significant growth in investments and market cap, largely due to expanding into the UK care home market and its first SHOP deal. The company reported substantial increases in normalized FFO and FAD per share and provided initial 2026 guidance, while maintaining a strong balance sheet and a robust investment pipeline. Management expressed confidence in continued growth, leveraged by an expanded team and diversified investment strategies in skilled nursing, senior housing, and UK care homes.
CareTrust REIT (CTRE) Q4 2025 Earnings Transcript
CareTrust REIT (CTRE) reported significant growth in Q4 2025, with normalized FFO up 42.7% sequentially and investments totaling $562 million. The company exceeded its 2024 investment record, reaching $1.8 billion for 2025, and provided 2026 guidance projecting a 9.4% increase in normalized FFO and FAD per share. Management highlighted strategic expansion into UK care homes and Senior Housing Operating Portfolio (SHOP) deals, alongside a robust $500 million investment pipeline.
After Inking First SHOP Deal in 2025, CareTrust REIT Looks for More Growth Opportunities
CareTrust REIT (NYSE: CTRE) is expanding its senior housing operating portfolio (SHOP) after closing its first SHOP deal in the fourth quarter of 2025 as part of $1.8 billion in total investments that year. The company is actively pursuing new growth opportunities, including U.K. care homes and further SHOP acquisitions, with a pipeline of $500 million. CareTrust acknowledges high competition in the SHOP space but believes its operational expertise, particularly from skilled nursing, gives it a competitive edge.
CareTrust REIT Reports Transformational Q4 2025 Earnings
CareTrust REIT reported a "transformational" Q4 2025, driven by $562 million in investments, including its first SHOP deal, and a 42.7% year-over-year increase in normalized FFO to $104.1 million. The company's market capitalization grew by 61% to $8.2 billion in 2025, and management projects a 9.4% increase in normalized FFO per share for 2026, indicating strong future growth prospects. Analysts have a "Moderate Buy" rating for CTRE, with price targets suggesting potential upside, citing the company's accretive acquisitions and benefits from aging demographics.
CareTrust REIT (CTRE) Q4 2025 Earnings Transcript
CareTrust REIT (CTRE) reported significant growth in Q4 and full-year 2025, with normalized FFO up 42.7% sequentially and total investments reaching $1.8 billion. The company expanded its portfolio into UK care homes and the Senior Housing Operating Portfolio (SHOP) sector, diversifying across geographies and asset types. For 2026, CareTrust REIT projects continued earnings per share growth, supported by a $500 million investment pipeline and strong liquidity, positioning it for further strategic acquisitions.
CareTrust REIT: Q4 Earnings Snapshot
CareTrust REIT Inc. (CTRE) announced its fourth-quarter earnings, reporting $104.1 million in funds from operations, or 47 cents per share. The real estate investment trust also reported a net income of $111.3 million, or 50 cents per share, and revenue of $134.9 million for the quarter. For the full year, the company had funds from operations of $359.7 million on revenue of $476.4 million, expecting full-year funds from operations to be between $1.90 and $1.95 per share.
CareTrust REIT: Q4 Earnings Snapshot
CareTrust REIT Inc. (CTRE) announced its fourth-quarter earnings, reporting funds from operations of $104.1 million, or 47 cents per share, and a net income of $111.3 million, or 50 cents per share. The healthcare real estate investment trust posted revenue of $134.9 million for the quarter. For the full year, the company's funds from operations totaled $359.7 million on revenue of $476.4 million, with an outlook for full-year funds from operations between $1.90 and $1.95 per share.
ProShare Advisors LLC Has $7.75 Million Position in CareTrust REIT, Inc. $CTRE
ProShare Advisors LLC has reduced its stake in CareTrust REIT (CTRE) by 10.9% in Q3, now holding 223,483 shares valued at approximately $7.75 million. Despite a 100% dividend payout ratio on its 3.4% yield, analysts maintain a "Moderate Buy" consensus with an average target price of $39, and several firms have recently raised their price objectives for CTRE. The stock recently opened at $39.34 and institutional investors own 87.77% of the company.
CareTrust REIT: Fourth Quarter Earnings Overview
CareTrust REIT announced its financial results for the fourth quarter, reporting funds from operations of $104.1 million (47 cents per share) and a net income of $111.3 million (50 cents per share). The company generated $134.9 million in revenue and projects full-year funds from operations to be between $1.90 and $1.95 per share. These figures highlight the REIT's profitability and provide an outlook for its future performance.
Allianz Asset Management GmbH Raises Stock Holdings in CareTrust REIT, Inc. $CTRE
Allianz Asset Management GmbH significantly increased its stake in CareTrust REIT, Inc. (NASDAQ:CTRE) by 133.4% in the third quarter of 2025, now holding 248,875 shares valued at approximately $8.63 million. Other institutional investors like Invesco Ltd., Daiwa Securities Group Inc., and Copeland Capital Management LLC also substantially boosted their holdings, leading to institutional investors owning 87.77% of the stock. CareTrust REIT maintains a "Moderate Buy" consensus rating from analysts with an average target price of $39.00, and the stock currently offers a dividend yield of around 3.5% with a 100% payout ratio.
BI Asset Management Fondsmaeglerselskab A S Purchases 67,817 Shares of CareTrust REIT, Inc. $CTRE
BI Asset Management Fondsmaeglerselskab A S significantly increased its stake in CareTrust REIT (NASDAQ:CTRE) by 545.9%, acquiring an additional 67,817 shares to bring its total holdings to 80,239 shares valued at $2.783 million. Other institutional investors like Royal Bank of Canada, NewEdge Advisors LLC, and KLP Kapitalforvaltning AS also adjusted their positions in CTRE. Analysts generally maintain a "Moderate Buy" rating for CareTrust REIT, with a consensus target price of $39.00 and a 3.4% annual dividend yield.
CareTrust REIT, Inc. (NASDAQ:CTRE) Given Average Recommendation of "Moderate Buy" by Analysts
CareTrust REIT, Inc. (NASDAQ:CTRE) has received an average rating of "Moderate Buy" from eleven analysts, with a consensus 12-month price target of $39.00. The company recently paid a quarterly dividend of $0.335 per share, representing an annualized yield of approximately 3.4%. Institutional investors own a significant portion of the stock, with shares trading near their 12-month high.
Thrivent Financial for Lutherans Sells 41,832 Shares of CareTrust REIT, Inc. $CTRE
Thrivent Financial for Lutherans reduced its stake in CareTrust REIT, Inc. (NASDAQ:CTRE) by 15.2% in the third quarter, selling 41,832 shares and ending with 232,583 shares valued at approximately $8.07 million. Despite this sale, other institutional investors like Invesco Ltd., Daiwa Securities Group Inc., and Copeland Capital Management LLC significantly increased their holdings. CareTrust REIT maintains a "Moderate Buy" consensus rating from analysts with an average price target of $39.00, and it offers a 3.5% annual dividend yield.
Caretrust Inc stock hits all-time high at 38.36 USD By Investing.com
Caretrust Inc stock has reached an all-time high of $38.36, representing a 42.42% increase over the past year and pushing its market capitalization to $8.54 billion. The company has also consistently raised its dividend for 10 consecutive years. Recent strategic moves include the acquisition of six skilled nursing facilities and positive analyst ratings, underscoring strong investor confidence and growth prospects.
Caretrust Inc stock hits all-time high at 38.36 USD
Caretrust Inc. stock has reached an all-time high of $38.36, surpassing its previous 52-week high, driven by a 42.42% increase over the past year and a 10-year consecutive dividend raise. The company, with an $8.54 billion market cap and 3.67% dividend yield, also recently acquired six skilled nursing facilities for $142 million and received upgraded analyst ratings, reflecting strong market confidence and strategic growth.
Caretrust Inc stock hits all-time high at 38.36 USD By Investing.com
Caretrust Inc. (CTRE) stock has reached an all-time high of $38.36, surpassing its previous 52-week high, driven by a 42.42% increase in stock price over the past year. The company boasts a market capitalization of $8.54 billion, a 3.67% dividend yield, and has raised its dividend for 10 consecutive years. Recent strategic acquisitions and analyst upgrades further underscore investor confidence and the company's strong financial health.
Caretrust Inc stock hits all-time high at 38.36 USD
Caretrust Inc. (CTRE) stock reached an all-time high of $38.36, surpassing its previous 52-week high, driven by a 42.42% increase over the past year. The company boasts a market capitalization of $8.54 billion, a 3.67% dividend yield, and has raised its dividend for 10 consecutive years. Recent strategic moves, including the acquisition of six skilled nursing facilities and positive analyst upgrades, underscore its robust performance and investor confidence.
BMO Capital Maintains CareTrust REIT Inc(CTRE.US) With Buy Rating, Maintains Target Price $43
BMO Capital has reiterated its Buy rating on CareTrust REIT Inc (CTRE.US) and maintained its price target of $43. This indicates continued analyst confidence in the company's stock performance.
How (CTRE) Movements Inform Risk Allocation Models
This article provides an analysis of Caretrust Reit Inc. (NASDAQ: CTRE) using AI models to inform risk allocation. It highlights a neutral near- and mid-term outlook with a possible moderation of a long-term positive bias, noting a mid-channel oscillation pattern. The analysis includes institutional trading strategies tailored to different risk profiles, offering specific entry, target, and stop-loss levels for position trading, momentum breakout, and risk hedging.
CareTrust REIT Sets Fourth Quarter Earnings Call for Friday, February 13, 2026
CareTrust REIT, Inc. announced that it will release its fourth-quarter and full-year 2025 financial results after market close on Thursday, February 12, 2026. The company will host a conference call on Friday, February 13, 2026, at 1:00 p.m. Eastern Time to discuss these results and other current matters. A live audio webcast will be available on the Investors section of CareTrust's website, with a replay accessible shortly after.
CareTrust REIT kicks off 2026 with SNF portfolio acquisition
CareTrust REIT has started 2026 with an off-market acquisition of six skilled nursing facilities in the Mid-Atlantic for approximately $142 million, effective January 1. The transaction was funded with cash on hand and is expected to generate a 9% stabilized yield, underscoring the company's disciplined growth strategy. This deal follows a strong 2025 where CareTrust made investments totaling approximately $1.8 billion, including expanding into the United Kingdom market.
Press Release: CareTrust REIT, Inc. Announces Tax Treatment of 2025 Dividends
CareTrust REIT, Inc. has announced the tax treatment of its 2025 dividends. This press release, published by Dow Jones, also briefly mentions Unity Software's Q4 financial results, including revenue beat and quarterly loss. Users need to log in to read the full details of the article.
A Look At CareTrust REIT’s (CTRE) Valuation After Recent Analyst Upgrades And Rising Earnings Estimates
CareTrust REIT (CTRE) is attracting investor attention due to recent analyst upgrades and rising earnings estimates. The article highlights that CTRE appears undervalued with an implied intrinsic discount of about 37% and a fair value of $41.36 per share, although its P/E ratio is higher than the global Health Care REITs average. The company's expanded investment pipeline and resilient operator relationships are seen as key drivers for future growth and higher fair value estimates.
Strs Ohio Has $5.90 Million Position in CareTrust REIT, Inc. $CTRE
Strs Ohio reduced its stake in CareTrust REIT, Inc. (NASDAQ:CTRE) by 49.9% in the 3rd quarter, now holding 170,160 shares valued at $5.90 million. Other institutional investors like Segall Bryant & Hamill LLC and Universal Beteiligungs und Servicegesellschaft mbH increased their holdings, significantly adding to the 87.77% institutional ownership. Analysts have a "Moderate Buy" consensus rating for CTRE with a target price of $39.00.
CareTrust REIT, Inc. Announces Tax Treatment of 2025 Dividends
CareTrust REIT, Inc. has released the tax status of its 2025 dividends for shareholders, detailing the classifications and distributions per share. The company clarifies that the dividend paid on January 15, 2026, for holders of record as of December 31, 2025, is considered a 2026 distribution for federal income tax purposes. Shareholders will receive Form 1099-DIV, and CareTrust advises consulting tax advisors as state and local treatments may differ.
How Analyst Upgrades and Rising Earnings Estimates Will Impact CareTrust REIT (CTRE) Investors
CareTrust REIT (CTRE) has received upbeat analyst actions, including an upgrade to Zacks Rank #2 (Buy) and a Market Outperform rating from Citizens, driven by improving earnings estimates. This positive sentiment reinforces the company's investment narrative, which relies on its healthcare-focused rental income, ability to reinvest capital, and commitment to growing dividends. Investors should, however, consider the stock's relatively high valuation, past shareholder dilution, and a still-young management team, despite the optimistic outlook.
CareTrust REIT, Inc. (NYSE:CTRE) Receives Consensus Rating of "Buy" from Brokerages
Five brokerage firms have issued a "Buy" consensus rating for CareTrust REIT, Inc. (NYSE:CTRE), with an average 12-month price target of $43.00. Recent analyst actions include upgrades from Citizens Jmp and UBS Group to "strong-buy," and BMO Capital Markets to "outperform." The company's recent earnings reported $0.35 EPS and $132.44 million in revenue, and it specializes in net-leased healthcare properties.
Universal Beteiligungs und Servicegesellschaft mbH Has $13.22 Million Stock Holdings in CareTrust REIT, Inc. $CTRE
Universal Beteiligungs und Servicegesellschaft mbH significantly increased its stake in CareTrust REIT Inc. by 24.4% in the third quarter, now holding 381,165 shares valued at $13.22 million. Wall Street analysts maintain a "Moderate Buy" consensus rating with an average target price of $39.00. CareTrust REIT recently announced a quarterly dividend of $0.335, resulting in an annualized yield of 3.6%.
How Investors May Respond To CareTrust REIT (CTRE) After Fresh Analyst Upgrades And Earnings Optimism
CareTrust REIT (CTRE) recently received positive analyst upgrades, including a Zacks Rank #2 (Buy) and "Market Outperform" coverage from Citizens, signaling growing confidence in its earnings outlook. While this attention can boost investor confidence and highlight earnings momentum, the stock still carries a relatively high valuation and its dividend coverage is thin, leaving less room for error. Investors should weigh the company's rapid earnings growth against its valuation and dividend sustainability.
CareTrust REIT (CTRE) upgraded to buy: Here's what you should know
This article announces that CareTrust REIT (CTRE) has received an upgrade to a "buy" rating. It suggests that investors should take note of this positive revision in its analyst rating and understand the implications for the company's stock.
Citizens Jmp Initiates Coverage on CareTrust REIT (NASDAQ:CTRE)
Citizens Jmp has initiated coverage on CareTrust REIT (NASDAQ:CTRE) with a "market outperform" rating and a $44 price target, suggesting a 17.7% upside. This follows several other analysts upgrading their price targets for CTRE. The company currently holds an average rating of "Moderate Buy" from analysts, with a consensus target price of $39.
CareTrust REIT's UK acquisition sets stage for diversified growth
This article details CareTrust REIT's strategic acquisition in the UK, signaling a move towards diversified growth. The expansion into the UK market is expected to open new avenues for the company. This acquisition is a significant development for CareTrust REIT's long-term strategy.
CareTrust REIT Inc (NYSE:CTRE) Shows Strong Growth and Technical Setup for Potential Breakout
CareTrust REIT Inc (CTRE) exhibits strong fundamental growth with impressive past and projected EPS and revenue increases, alongside high profitability and sound financial health. Technically, the stock is in a clear uptrend, trading near its 52-week highs within a range, suggesting a potential breakout. While its valuation rating is neutral, its low PEG ratio indicates it might be reasonably priced given its high expected growth, making it an interesting candidate for investors focusing on combined growth and momentum strategies.
A Look At CareTrust REIT (CTRE) Valuation After Mid Atlantic Acquisitions And Leadership Changes
CareTrust REIT (CTRE) has expanded its portfolio through a US$142 million acquisition of six skilled nursing facilities in the Mid Atlantic region and announced leadership changes. The company's shares are currently trading at a discount to analyst price targets and modeled intrinsic value, suggesting a potential buying opportunity. This expansion and the company's focus on net leased healthcare properties contribute to a narrative of undervaluation and strong long-term growth prospects.
How Investors Are Reacting To CareTrust REIT (CTRE) Expanding Skilled Nursing Portfolio And Deepening Leadership Bench
CareTrust REIT (CTRE) recently acquired six Mid-Atlantic skilled nursing facilities for US$142 million and made several senior promotions to strengthen its leadership bench. This move indicates a focus on scaling healthcare properties and tightening operational oversight, a key factor for investors assessing the company's ability to integrate rapid portfolio growth effectively. The article discusses CareTrust's investment narrative, including revenue and earnings forecasts, and highlights varied fair value estimates from the Simply Wall St Community.
CareTrust REIT Inc (NYSE:CTRE) Shows Strong Technical Setup for Potential Breakout
CareTrust REIT Inc (NYSE:CTRE) exhibits a strong technical setup, indicative of a potential breakout. The company shows a top Technical Rating of 10/10, suggesting a clear uptrend and market outperformance. With a Setup Quality rating of 9, CTRE is currently consolidating in a narrow range, offering a defined entry point for momentum-focused investors.
How Investors Are Reacting To CareTrust REIT (CTRE) Expanding Skilled Nursing Portfolio And Deepening Leadership Bench
CareTrust REIT (CTRE) recently acquired six Mid-Atlantic skilled nursing facilities for US$142 million and made several senior promotions and hires, signaling a strategic focus on expanding its healthcare property portfolio and strengthening operational expertise. The company's future performance hinges on its ability to effectively integrate rapid growth without compromising margins, particularly within the skilled nursing sector. While the company forecasts significant revenue and earnings growth, investor perspectives on its fair value vary widely, reflecting the perceived risks and opportunities associated with its expansion strategy.
